Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men: Fossa SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, Travis LB, Department of Clinical Cancer Research, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway

Autor: Rowland, Randall G.

Publikováno v: In Urologic Oncology: Seminars and Original Investigations 2006 24(2):173-173

Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis.

Autor: Valcarcel B; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD. bryan.valcarcel@nih.gov., Schonfeld SJ; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD., Shiels MS; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland., Castillo JJ; Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA., Morton LM; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD.

Publikováno v: Haematologica [Haematologica] 2024 Oct 31. Date of Electronic Publication: 2024 Oct 31.

Commentary on 'Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010.' Karami S, Daugherty SE, Schonfeld SJ, Park Y, Hollenbeck AR, Grubb RL 3rd, Hofmann JN, Chow WH, Purdue MP, Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD

Autor: Stephen A. Boorjian

Publikováno v: Urologic Oncology: Seminars and Original Investigations. 32:932-933

Clinical and experimental findings suggest that female hormonal and reproductive factors could influence kidney cancer development. To evaluate this association, we conducted analyses in 2 large prospective cohorts (the National Institutes of Health�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1379d6899f4f2ee56034ed7be2a20162
https://doi.org/10.1016/j.urolonc.2014.01.014

Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry.

Autor: Schonfeld SJ; Division of Cancer Epidemiology and Genetics, National Institutes of Health, Department of Health and Human Services, National Cancer Institute, Bethesda, MD., Valcarcel B; Division of Cancer Epidemiology and Genetics, National Institutes of Health, Department of Health and Human Services, National Cancer Institute, Bethesda, MD., Meyer CL; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN., Shaw BE; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Phelan R; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.; Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., Rizzo JD; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Brunson A; Division of Hematology and Oncology, Center for Oncology and Hematology Outcomes Research and Training, University of California Davis Comprehensive Cancer Center, Sacramento, CA., Cooley JJP; California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, CA., Abrahão R; Division of Hematology and Oncology, Center for Oncology and Hematology Outcomes Research and Training, University of California Davis Comprehensive Cancer Center, Sacramento, CA., Wun T; Division of Hematology and Oncology, Center for Oncology and Hematology Outcomes Research and Training, University of California Davis Comprehensive Cancer Center, Sacramento, CA.; California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, CA., Gadalla SM; Division of Cancer Epidemiology and Genetics, National Institutes of Health, Department of Health and Human Services, National Cancer Institute, Bethesda, MD., Engels E; Division of Cancer Epidemiology and Genetics, National Institutes of Health, Department of Health and Human Services, National Cancer Institute, Bethesda, MD., Albert PS; Division of Cancer Epidemiology and Genetics, National Institutes of Health, Department of Health and Human Services, National Cancer Institute, Bethesda, MD., Yusuf R; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN., Spellman SR; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN., Curtis RE; Division of Cancer Epidemiology and Genetics, National Institutes of Health, Department of Health and Human Services, National Cancer Institute, Bethesda, MD., Auletta JJ; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN.; Divisions of Hematology, Oncology & Blood and Marrow Transplant and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH., Muffly L; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA., Keegan THM; Division of Hematology and Oncology, Center for Oncology and Hematology Outcomes Research and Training, University of California Davis Comprehensive Cancer Center, Sacramento, CA.; California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, CA., Morton LM; Division of Cancer Epidemiology and Genetics, National Institutes of Health, Department of Health and Human Services, National Cancer Institute, Bethesda, MD.

Publikováno v: Blood advances [Blood Adv] 2024 Aug 13; Vol. 8 (15), pp. 4102-4112.

Genomic characterization of cervical lymph node metastases in papillary thyroid carcinoma following the Chornobyl accident.

Autor: Morton LM; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. mortonli@mail.nih.gov., Lee OW; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Karyadi DM; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Bogdanova TI; Laboratory of Morphology of the Endocrine System, V.P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine., Stewart C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hartley SW; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Breeze CE; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schonfeld SJ; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Cahoon EK; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Drozdovitch V; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Masiuk S; National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine., Chepurny M; National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine., Zurnadzhy LY; Laboratory of Morphology of the Endocrine System, V.P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine., Dai J; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD, USA., Krznaric M; Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, United Kingdom., Yeager M; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD, USA., Hutchinson A; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD, USA., Hicks BD; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD, USA., Dagnall CL; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD, USA., Steinberg MK; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD, USA., Jones K; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD, USA., Jain K; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD, USA., Jordan B; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD, USA., Machiela MJ; Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Dawson ET; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Nvidia Corporation, Santa Clara, CA, USA., Vij V; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Gastier-Foster JM; Nationwide Children's Hospital, Biospecimen Core Resource, Columbus, OH, USA.; Departments of Pathology and Pediatrics, Ohio State University College of Medicine, Columbus, OH, USA., Bowen J; Nationwide Children's Hospital, Biospecimen Core Resource, Columbus, OH, USA., Mabuchi K; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Hatch M; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Berrington de Gonzalez A; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tronko MD; Department of Fundamental and Applied Problems of Endocrinology, V.P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine., Thomas GA; Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, United Kingdom., Chanock SJ; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. chanocks@mail.nih.gov.

Publikováno v: Nature communications [Nat Commun] 2024 Jun 13; Vol. 15 (1), pp. 5053. Date of Electronic Publication: 2024 Jun 13.